Rankings
▼
Calendar
OCGN FY 2020 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$578M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$43,000
Gross Profit
-$6M
-14676.7% margin
Operating Income
-$21M
-49500.0% margin
Net Income
-$22M
-50748.8% margin
EPS (Diluted)
$-0.31
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$660,000
Balance Sheet
Total Assets
$27M
Total Liabilities
$6M
Stockholders' Equity
$22M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$43,000
$0
—
Gross Profit
-$6M
-$8M
+22.0%
Operating Income
-$21M
-$14M
-50.3%
Net Income
-$22M
-$20M
-7.8%
← Q4 2019
All Quarters
Q1 2020 →